CN113122561B - Expression vector of membrane protein SohB and expression and purification method thereof - Google Patents

Expression vector of membrane protein SohB and expression and purification method thereof Download PDF

Info

Publication number
CN113122561B
CN113122561B CN202010049420.4A CN202010049420A CN113122561B CN 113122561 B CN113122561 B CN 113122561B CN 202010049420 A CN202010049420 A CN 202010049420A CN 113122561 B CN113122561 B CN 113122561B
Authority
CN
China
Prior art keywords
sohb
expression
membrane protein
expression vector
coli
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010049420.4A
Other languages
Chinese (zh)
Other versions
CN113122561A (en
Inventor
周敏
张苑桢
陈宇航
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing University of Science and Technology
Original Assignee
Nanjing University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing University of Science and Technology filed Critical Nanjing University of Science and Technology
Priority to CN202010049420.4A priority Critical patent/CN113122561B/en
Publication of CN113122561A publication Critical patent/CN113122561A/en
Application granted granted Critical
Publication of CN113122561B publication Critical patent/CN113122561B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The invention discloses an expression vector of membrane protein SohB and an expression and purification method thereof. The nucleotide sequence of the expression vector is shown as SEQ ID NO.2, and comprises: phage T7 promoter; an E.coli ribosome binding site comprising the sequence CCATGG of NcoI, the sequence SohB of E.coli membrane protein shown in SEQ ID NO.1 and the BamHI site GGATCC; tobacco etch virus cysteine protease cleavage site GAGAACCTGTACTTCCAATCC; ndeI restriction enzyme site CATATG; a super-folded Venus fluorescent protein coding sequence; xhoI cleavage site CTCGAG;6 histidine sites and stop codon TAG. The invention uses the fluorescent protein with molecular rigidity as a screening mark and an expression progress indicator, and the fluorescent protein can be rapidly folded due to the molecular level rigid structure, so that the nitrogen end membrane protein SohB can be helped to stabilize the conformation. The expression vector constructed by the invention can realize the mass expression of membrane protein SohB, and can be used for the subsequent high-throughput screening of novel antibiotics.

Description

Expression vector of membrane protein SohB and expression and purification method thereof
Technical Field
The invention belongs to the technical field of protein production, and relates to an expression vector of a functional unknown transport protein (SohB) and an expression and purification method thereof.
Background
Cell membranes are the boundary between the inside and outside of cells, and are the most important organelles, carrying important functions of information transfer, energy transfer and mass exchange. Targets for drug action are often located on cell membranes. It is currently known that more than 50% of the targets of drug action are membrane proteins. Therefore, the method has very important significance for researching membrane proteins.
However, membrane proteins have a structure of multiple transmembrane processes due to their scarce content in their natural state, and thus are prone to errors in folding and have a complex structure, so that large-scale production of membrane proteins has been a difficulty and a hot spot. In China, no biological company can express more than 12 times of transmembrane proteins, and only one or two companies can express four times of transmembrane proteins.
Coli has been the first choice for protein expression as a commonly used expression host, however, even the E.coli self-protein is difficult to express in large quantities in E.coli. At present, the abuse of antibiotics faces the embarrassment of being unable to fight drug-resistant bacteria in the next 50 years. Therefore, the method provides a pilot technical support for the high-throughput screening of the follow-up non-denaturing mass spectrum by using a large amount of expressed membrane proteins as the acting targets of antibiotics.
Disclosure of Invention
The invention aims to provide an expression vector for expressing a large amount of membrane protein SohB and an expression and purification method thereof. The invention establishes a high-efficiency fusion expression system aiming at escherichia coli membrane protein SohB, and can be used for subsequent further protein non-denaturation real-time monitoring mass spectrum research.
The technical scheme for realizing the purpose of the invention is as follows:
the membrane protein SohB expression vector of the invention takes the hyper-folding Venus fluorescent protein (Chinese patent application 201910347575.3) for positioning the chlamydomonas reinhardtii protein obtained in the laboratory as an initial protein skeleton, and obtains a fluorescent protein expression tag with molecular rigidity by further optimizing codon composition used for sequence expression, and is suitable for large-scale expression of escherichia coli membrane protein. The invention uses the fluorescent protein with molecular rigidity as a screening mark and an expression progress indicator, and the fluorescent protein can be rapidly folded due to the molecular level rigid structure, and helps the nitrogen end membrane protein SohB to stabilize the conformation thereof.
The expression vector of the membrane protein SohB is expression plasmid pLy077-SohB (SEQ ID NO. 2), and comprises: phage T7 promoter; an E.coli ribosome binding site comprising the sequence NcoI, CCATGG, the E.coli membrane protein SohB sequence (SEQ ID NO. 1) and the BamHI site GGATCC; tobacco etch virus cysteine protease cleavage site GAGAACCTGTACTTCCAATCC; ndeI restriction enzyme site CATATG; a super-folded Venus fluorescent protein coding sequence; xhoI cleavage site CTCGAG;6 histidine sites and stop codon TAG.
The invention also provides an expression and purification method of the membrane protein SohB expression vector, which comprises the following specific steps:
step 1, preparation of an escherichia coli membrane protein SohB expression vector mutant strain: transforming an expression vector of membrane protein SohB, namely expression plasmid pLy077-SohB, into host escherichia coli, coating the host escherichia coli with an antibiotic-containing and 0.1mM IPTG agar plate, and selecting yellow-green positive monoclonal bacteria for amplification culture and induced expression;
step 2, inoculating the selected mutant strain transformant into a culture medium for expansion culture, and using 1mM IPTG to induce and express membrane protein SohB on a large scale.
Preferably, in step 1, the E.coli is E.coli DH 5. Alpha. Or E.coli BL21 (DE 3).
Preferably, in step 2, the culture medium is LB culture medium or TB culture medium.
The invention introduces the target gene and the super-folding Venus fluorescent protein with molecular rigidity which is optimized by codons into the expression vector through the total synthesis of the expression vector, and greatly improves the transcription and translation efficiency of the target gene through optimizing the nucleic acid coding primary sequence. In addition, by controlling the folding rate of the carboxy-terminal rigid fluorescent protein, the target membrane protein is helped to fold correctly and insert into the membrane. The rigid fluorescent protein can be used for monitoring the real-time expression process of the protein and protecting the carboxyl end of the protein, so that the target protein is enriched. The invention realizes high-flux screening of novel antibiotics by expressing a large amount of escherichia coli membrane protein and purifying the escherichia coli membrane protein in the later period, and has important commercialized prospect.
Drawings
FIG. 1 is a diagram showing the result of PCR agarose gel electrophoresis of the coding sequence of SohB nucleic acid.
FIG. 2 is a schematic diagram of the structure of the pLy077-SohB plasmid.
FIG. 3 is a graph showing the results of PCR assay of pLy077-SohB colonies.
FIG. 4 is a graph showing the result of single-cut double-cut agarose gel electrophoresis of NcoI and BamHI of plasmid pLy 077-SohB.
FIG. 5 is a fluorescent image of colonies on a transformation agar plate.
FIG. 6 is a graph showing fluorescence imaging after induction and comparing whole mycoproteins before and after induction.
Detailed Description
The invention is further described below with reference to specific examples and figures, but is not limited thereto. The procedures, conditions, reagents, experimental methods, etc. for carrying out the present invention are common knowledge and common knowledge in the art, except for those specifically mentioned below, and the present invention is not particularly limited.
The materials used in the examples are as follows:
1. cell origin
Coli DH 5. Alpha., BL21 (DE 3), C41 (DE 3), C43 (DE 3) strains were purchased from Wuhan Ling vast Biocompany.
2. Plasmid origin
pLy077 plasmid and SohB coding sequence were synthesized by Shanghai Biotechnology Inc., pLy077 plasmid comprises: phage T7 promoter; an E.coli ribosome binding site comprising the NcoI sequence CCATGG and the BamHI site GGATCC; tobacco etch virus cysteine protease cleavage site GAGAACCTGTACTTCCAATCC; ndeI restriction enzyme site CATATG; a super-folded Venus fluorescent protein coding sequence; xhoI cleavage site CTCGAG;6 histidine sites and stop codon TAG. The pLy077 plasmid and SohB coding sequence are shown in the sequence table.
3. Primer source
The synthetic primers were all from Beijing Optimu Biotechnology Co.
4. Main reagent
Tryptone, yeast extract, naCl, tris-base were all purchased from Sigma company; restriction endonucleases, phusion enzymes were purchased from Thermo Fisher company; rTaq enzyme, T4 ligase was purchased from Takara. Plasmid miniprep kit and gel recovery kit were purchased from Axygen company. NTP, DEPC water, RNase inhibitor were purchased from Shanghai Biotechnology Inc.
EXAMPLE 1 Gene cloning of SohB
Cloning of SohB
a) A brand new SohB coding sequence (SEQ ID NO. 1) is designed and synthesized according to the codon usage frequency of the SohB sequence and the Escherichia coli codon usage frequency under the Kazusa online database (http:// www.kazusa.or.jp/codon /). And then amplified by a PCR method. The PCR reaction system configuration is shown in Table 1.
TABLE 1 preparation of PCR reaction System Table
The PCR results are shown in FIG. 1. The length of the target fragment is 1068bp, and the optimal annealing temperature is 52 ℃.
b) Recovering target DNA, cutting target fragment and pLy077 vector with NcoI and BamHI, performing agarose gel electrophoresis, and recovering enzyme cutting product; the recovered target fragment and pLy077 vector fragment were added to a small centrifuge tube at a molar ratio of 5:1, T4 ligase was added, and ligation was performed overnight at 16 ℃.
c) 20. Mu.L of the above ligation product was transformed into 80. Mu.L of DH 5. Alpha. Competent cells by a heat shock method at 42℃and placed in a shaker at 37℃after 700. Mu.L of LB medium, followed by culturing at 200 rpm for 45 minutes.
d) Centrifuging the bacterial liquid at 4000 rpm for 1 minute, and sucking 700 mu L of supernatant; after the residual medium was gently sucked by pipetting, it was spread on LB solid plates containing ampicillin, inverted and incubated in an incubator at 37℃for 12 hours.
e) The single colony in the flat plate is selected, a plasmid is extracted after a small amount of amplification, the extracted plasmid is subjected to single enzyme digestion and double enzyme digestion by using NcoI and BamHI, then agarose gel electrophoresis identification is carried out, sequencing identification is carried out correctly, and the expression vector pLy077-SohB of membrane protein SohB is obtained, and the structural schematic diagram of the plasmid is shown in figure 2. FIG. 3 is a graph showing the results of PCR assay of pLy077-SohB colonies. FIG. 4 is a graph showing the result of single-cut double-cut agarose gel electrophoresis of NcoI and BamHI of plasmid pLy 077-SohB.
EXAMPLE 2SohB expression
Induction expression of fusion protein SohB-super folding fluorescent protein
Transferring the pLy077-SohB plasmid which is identified correctly into an escherichia coli expression host BL21 (DE 3) and DH5 alpha, and coating the escherichia coli expression host BL21 and DH5 alpha on a colony containing 0.1mM isopropyl thiogalactoside (IPTG) to obtain stable transformation; by detecting fluorescence of colonies, FIG. 5 is a graph showing fluorescence of colonies on a transformation agar plate, and it can be seen that a large amount of mutants expressing a target protein were obtained, since the presence or absence of fluorescence can be used to determine whether the colonies contain a recombinant plasmid, and the colonies containing the recombinant plasmid exhibit fluorescence.
Single colonies were inoculated into LB and TB liquid media containing 100. Mu.g/ml ampicillin, and cultured overnight at 37℃at 200 rpm to give overnight bacteria. Inoculating overnight bacteria into 750mL LB and TB culture medium at a ratio of 1:250, culturing at 30deg.C to OD at 230 rpm 600 Reaching 0.8-1.0, adding IPTG with final concentration of 0.5mM, and culturing at 25deg.C for 2-6 hr. The cells were collected by centrifugation at 4000 rpm for 15 minutes. And (3) suspending the strain in PBS buffer solution, and centrifuging for 15 minutes at 4000 rpm to obtain the strain containing the SohB fusion expression protein. FIG. 6 is a graph showing fluorescence imaging after induction and comparing whole mycoproteins before and after induction. As can be seen from FIG. 6, the E.coli BL21 (DE 3) was used as the expression strain, and after 4 hours of induction in TB medium, the SohB protein expression level was the highest.
Sequence listing
<110> university of Nanjing's science
<120> expression vector of membrane protein SohB and expression purification method thereof
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1047
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 1
atggaactgc tgagcgaata tggcctgttt ctggcgaaaa ttgtgaccgt ggtgctggcg 60
attgcggcga ttgcggcgat tattgtgaac gtggcgcagc gcaacaaacg ccagcgcggc 120
gaactgcgcg tgaacaacct gagcgaacag tataaagaaa tgaaagaaga actggcggcg 180
gcgctgatgg atagccatca gcagaaacag tggcataaag cgcagaaaaa aaaacataaa 240
caggaagcga aagcggcgaa agcgaaagcg aaactgggcg aagtggcgac cgatagcaaa 300
ccgcgcgtgt gggtgctgga ttttaaaggc agcatggatg cgcatgaagt gaacagcctg 360
cgcgaagaaa ttaccgcggt gctggcggcg tttaaaccgc aggatcaggt ggtgctgcgc 420
ctggaaagcc cgggcggcat ggtgcatggc tatggcctgg cggcgagcca gctgcagcgc 480
ctgcgcgata aaaacattcc gctgaccgtg accgtggata aagtggcggc gagcggcggc 540
tatatgatgg cgtgcgtggc ggataaaatt gtgagcgcgc cgtttgcgat tgtgggcagc 600
attggcgtgg tggcgcagat gccgaacttt aaccgctttc tgaaaagcaa agatattgat 660
attgaactgc ataccgcggg ccagtataaa cgcaccctga ccctgctggg cgaaaacacc 720
gaagaaggcc gcgaaaaatt tcgcgaagaa ctgaacgaaa cccatcagct gtttaaagat 780
tttgtgaaac gcatgcgccc gagcctggat attgaacagg tggcgaccgg cgaacattgg 840
tatggccagc aggcggtgga aaaaggcctg gtggatgaaa ttaacaccag cgatgaagtg 900
attctgagcc tgatggaagg ccgcgaagtg gtgaacgtgc gctatatgca gcgcaaacgc 960
ctgattgatc gctttaccgg cagcgcggcg gaaagcgcgg atcgcctgct gctgcgctgg 1020
tggcagcgcg gccagaaacc gctgatg 1047
<210> 2
<211> 7042
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 2
tggcgaatgg gacgcgccct gtagcggcgc attaagcgcg gcgggtgtgg tggttacgcg 60
cagcgtgacc gctacacttg ccagcgccct agcgcccgct cctttcgctt tcttcccttc 120
ctttctcgcc acgttcgccg gctttccccg tcaagctcta aatcgggggc tccctttagg 180
gttccgattt agtgctttac ggcacctcga ccccaaaaaa cttgattagg gtgatggttc 240
acgtagtggg ccatcgccct gatagacggt ttttcgccct ttgacgttgg agtccacgtt 300
ctttaatagt ggactcttgt tccaaactgg aacaacactc aaccctatct cggtctattc 360
ttttgattta taagggattt tgccgatttc ggcctattgg ttaaaaaatg agctgattta 420
acaaaaattt aacgcgaatt ttaacaaaat attaacgttt acaatttcag gtggcacttt 480
tcggggaaat gtgcgcggaa cccctatttg tttatttttc taaatacatt caaatatgta 540
tccgctcatg aattaattct tagaaaaact catcgagcat caaatgaaac tgcaatttat 600
tcatatcagg attatcaata ccatattttt gaaaaagccg tttctgtaat gaaggagaaa 660
actcaccgag gcagttccat aggatggcaa gatcctggta tcggtctgcg attccgactc 720
gtccaacatc aatacaacct attaatttcc cctcgtcaaa aataaggtta tcaagtgaga 780
aatcaccatg agtgacgact gaatccggtg agaatggcaa aagtttatgc atttctttcc 840
agacttgttc aacaggccag ccattacgct cgtcatcaaa atcactcgca tcaaccaaac 900
cgttattcat tcgtgattgc gcctgagcga gacgaaatac gcgatcgctg ttaaaaggac 960
aattacaaac aggaatcgaa tgcaaccggc gcaggaacac tgccagcgca tcaacaatat 1020
tttcacctga atcaggatat tcttctaata cctggaatgc tgttttcccg gggatcgcag 1080
tggtgagtaa ccatgcatca tcaggagtac ggataaaatg cttgatggtc ggaagaggca 1140
taaattccgt cagccagttt agtctgacca tctcatctgt aacatcattg gcaacgctac 1200
ctttgccatg tttcagaaac aactctggcg catcgggctt cccatacaat cgatagattg 1260
tcgcacctga ttgcccgaca ttatcgcgag cccatttata cccatataaa tcagcatcca 1320
tgttggaatt taatcgcggc ctagagcaag acgtttcccg ttgaatatgg ctcataacac 1380
cccttgtatt actgtttatg taagcagaca gttttattgt tcatgaccaa aatcccttaa 1440
cgtgagtttt cgttccactg agcgtcagac cccgtagaaa agatcaaagg atcttcttga 1500
gatccttttt ttctgcgcgt aatctgctgc ttgcaaacaa aaaaaccacc gctaccagcg 1560
gtggtttgtt tgccggatca agagctacca actctttttc cgaaggtaac tggcttcagc 1620
agagcgcaga taccaaatac tgtccttcta gtgtagccgt agttaggcca ccacttcaag 1680
aactctgtag caccgcctac atacctcgct ctgctaatcc tgttaccagt ggctgctgcc 1740
agtggcgata agtcgtgtct taccgggttg gactcaagac gatagttacc ggataaggcg 1800
cagcggtcgg gctgaacggg gggttcgtgc acacagccca gcttggagcg aacgacctac 1860
accgaactga gatacctaca gcgtgagcta tgagaaagcg ccacgcttcc cgaagggaga 1920
aaggcggaca ggtatccggt aagcggcagg gtcggaacag gagagcgcac gagggagctt 1980
ccagggggaa acgcctggta tctttatagt cctgtcgggt ttcgccacct ctgacttgag 2040
cgtcgatttt tgtgatgctc gtcagggggg cggagcctat ggaaaaacgc cagcaacgcg 2100
gcctttttac ggttcctggc cttttgctgg ccttttgctc acatgttctt tcctgcgtta 2160
tcccctgatt ctgtggataa ccgtattacc gcctttgagt gagctgatac cgctcgccgc 2220
agccgaacga ccgagcgcag cgagtcagtg agcgaggaag cggaagagcg cctgatgcgg 2280
tattttctcc ttacgcatct gtgcggtatt tcacaccgca tatatggtgc actctcagta 2340
caatctgctc tgatgccgca tagttaagcc agtatacact ccgctatcgc tacgtgactg 2400
ggtcatggct gcgccccgac acccgccaac acccgctgac gcgccctgac gggcttgtct 2460
gctcccggca tccgcttaca gacaagctgt gaccgtctcc gggagctgca tgtgtcagag 2520
gttttcaccg tcatcaccga aacgcgcgag gcagctgcgg taaagctcat cagcgtggtc 2580
gtgaagcgat tcacagatgt ctgcctgttc atccgcgtcc agctcgttga gtttctccag 2640
aagcgttaat gtctggcttc tgataaagcg ggccatgtta agggcggttt tttcctgttt 2700
ggtcactgat gcctccgtgt aagggggatt tctgttcatg ggggtaatga taccgatgaa 2760
acgagagagg atgctcacga tacgggttac tgatgatgaa catgcccggt tactggaacg 2820
ttgtgagggt aaacaactgg cggtatggat gcggcgggac cagagaaaaa tcactcaggg 2880
tcaatgccag cgcttcgtta atacagatgt aggtgttcca cagggtagcc agcagcatcc 2940
tgcgatgcag atccggaaca taatggtgca gggcgctgac ttccgcgttt ccagacttta 3000
cgaaacacgg aaaccgaaga ccattcatgt tgttgctcag gtcgcagacg ttttgcagca 3060
gcagtcgctt cacgttcgct cgcgtatcgg tgattcattc tgctaaccag taaggcaacc 3120
ccgccagcct agccgggtcc tcaacgacag gagcacgatc atgcgcaccc gtggggccgc 3180
catgccggcg ataatggcct gcttctcgcc gaaacgtttg gtggcgggac cagtgacgaa 3240
ggcttgagcg agggcgtgca agattccgaa taccgcaagc gacaggccga tcatcgtcgc 3300
gctccagcga aagcggtcct cgccgaaaat gacccagagc gctgccggca cctgtcctac 3360
gagttgcatg ataaagaaga cagtcataag tgcggcgacg atagtcatgc cccgcgccca 3420
ccggaaggag ctgactgggt tgaaggctct caagggcatc ggtcgagatc ccggtgccta 3480
atgagtgagc taacttacat taattgcgtt gcgctcactg cccgctttcc agtcgggaaa 3540
cctgtcgtgc cagctgcatt aatgaatcgg ccaacgcgcg gggagaggcg gtttgcgtat 3600
tgggcgccag ggtggttttt cttttcacca gtgagacggg caacagctga ttgcccttca 3660
ccgcctggcc ctgagagagt tgcagcaagc ggtccacgct ggtttgcccc agcaggcgaa 3720
aatcctgttt gatggtggtt aacggcggga tataacatga gctgtcttcg gtatcgtcgt 3780
atcccactac cgagatatcc gcaccaacgc gcagcccgga ctcggtaatg gcgcgcattg 3840
cgcccagcgc catctgatcg ttggcaacca gcatcgcagt gggaacgatg ccctcattca 3900
gcatttgcat ggtttgttga aaaccggaca tggcactcca gtcgccttcc cgttccgcta 3960
tcggctgaat ttgattgcga gtgagatatt tatgccagcc agccagacgc agacgcgccg 4020
agacagaact taatgggccc gctaacagcg cgatttgctg gtgacccaat gcgaccagat 4080
gctccacgcc cagtcgcgta ccgtcttcat gggagaaaat aatactgttg atgggtgtct 4140
ggtcagagac atcaagaaat aacgccggaa cattagtgca ggcagcttcc acagcaatgg 4200
catcctggtc atccagcgga tagttaatga tcagcccact gacgcgttgc gcgagaagat 4260
tgtgcaccgc cgctttacag gcttcgacgc cgcttcgttc taccatcgac accaccacgc 4320
tggcacccag ttgatcggcg cgagatttaa tcgccgcgac aatttgcgac ggcgcgtgca 4380
gggccagact ggaggtggca acgccaatca gcaacgactg tttgcccgcc agttgttgtg 4440
ccacgcggtt gggaatgtaa ttcagctccg ccatcgccgc ttccactttt tcccgcgttt 4500
tcgcagaaac gtggctggcc tggttcacca cgcgggaaac ggtctgataa gagacaccgg 4560
catactctgc gacatcgtat aacgttactg gtttcacatt caccaccctg aattgactct 4620
cttccgggcg ctatcatgcc ataccgcgaa aggttttgcg ccattcgatg gtgtccggga 4680
tctcgacgct ctcccttatg cgactcctgc attaggaagc agcccagtag taggttgagg 4740
ccgttgagca ccgccgccgc aaggaatggt gcatgcaagg agatggcgcc caacagtccc 4800
ccggccacgg ggcctgccac catacccacg ccgaaacaag cgctcatgag cccgaagtgg 4860
cgagcccgat cttccccatc ggtgatgtcg gcgatatagg cgccagcaac cgcacctgtg 4920
gcgccggtga tgccggccac gatgcgtccg gcgtagagga tcgagatctc gatcccgcga 4980
aattaatacg actcactata ggggaattgt gagcggataa caattcccct ctagaaataa 5040
ttttgtttaa ctttaagaag gagatatacc atgggcatgg aactgctgag cgaatatggc 5100
ctgtttctgg cgaaaattgt gaccgtggtg ctggcgattg cggcgattgc ggcgattatt 5160
gtgaacgtgg cgcagcgcaa caaacgccag cgcggcgaac tgcgcgtgaa caacctgagc 5220
gaacagtata aagaaatgaa agaagaactg gcggcggcgc tgatggatag ccatcagcag 5280
aaacagtggc ataaagcgca gaaaaaaaaa cataaacagg aagcgaaagc ggcgaaagcg 5340
aaagcgaaac tgggcgaagt ggcgaccgat agcaaaccgc gcgtgtgggt gctggatttt 5400
aaaggcagca tggatgcgca tgaagtgaac agcctgcgcg aagaaattac cgcggtgctg 5460
gcggcgttta aaccgcagga tcaggtggtg ctgcgcctgg aaagcccggg cggcatggtg 5520
catggctatg gcctggcggc gagccagctg cagcgcctgc gcgataaaaa cattccgctg 5580
accgtgaccg tggataaagt ggcggcgagc ggcggctata tgatggcgtg cgtggcggat 5640
aaaattgtga gcgcgccgtt tgcgattgtg ggcagcattg gcgtggtggc gcagatgccg 5700
aactttaacc gctttctgaa aagcaaagat attgatattg aactgcatac cgcgggccag 5760
tataaacgca ccctgaccct gctgggcgaa aacaccgaag aaggccgcga aaaatttcgc 5820
gaagaactga acgaaaccca tcagctgttt aaagattttg tgaaacgcat gcgcccgagc 5880
ctggatattg aacaggtggc gaccggcgaa cattggtatg gccagcaggc ggtggaaaaa 5940
ggcctggtgg atgaaattaa caccagcgat gaagtgattc tgagcctgat ggaaggccgc 6000
gaagtggtga acgtgcgcta tatgcagcgc aaacgcctga ttgatcgctt taccggcagc 6060
gcggcggaaa gcgcggatcg cctgctgctg cgctggtggc agcgcggcca gaaaccgctg 6120
atgggatccg gactgcagga gaacctgtac ttccaatccc accatatgtc taaaggtgaa 6180
gaactgttca ccggtgttgt tccgatcctg gttgaactgg acggtgacgt taacggtcac 6240
aaattctctg ttcgtggtga aggtgaaggt gacgctacca acggtaaact gaccctgaaa 6300
ttcatctgca ccaccggtaa actgccggtt ccgtggccga ccctggttac caccctgacc 6360
tacggtgttc agtgcttctc tcgttacccg gaccacatga aacgtcacga cttcttcaaa 6420
tctgctatgc cggaaggtta cgttcaggaa cgtaccatct ctttcaaaga cgacggtacc 6480
tacaaaaccc gtgctgaagt taaattcgaa ggtgacaccc tggttaaccg tatcgaactg 6540
aaaggtatcg acttcaaaga agacggtaac atcctgggtc acaaactgga atacaacttc 6600
aactctcaca acgtttacat caccgctgac aaacagaaaa acggtatcaa agctaacttc 6660
aaaatccgtc acaacgttga agacggttct gttcagctgg ctgaccacta ccagcagaac 6720
accccgatcg gtgacggtcc ggttctgctg ccggacaacc actacctgtc tacccagtct 6780
gttctgtcta aagacccgaa cgaaaaacgt gaccacatgg ttctgctgga attcgttacc 6840
gctgctggta tcacccacgg tatggacgaa ctgtacaaac tcgagcacca ccaccaccac 6900
cactgagatc cggctgctaa caaagcccga aaggaagctg agttggctgc tgccaccgct 6960
gagcaataac tagcataacc ccttggggcc tctaaacggg tcttgagggg ttttttgctg 7020
aaaggaggaa ctatatccgg at 7042

Claims (4)

1. The expression vector of the membrane protein SohB is characterized in that the expression vector is an expression plasmid pLy077-SohB, the nucleotide sequence of which is shown as SEQ ID NO.2, and comprises: phage T7 promoter; e.coli ribosome binding sites; an NcoI sequence CCATGG, an escherichia coli membrane protein SohB sequence shown in SEQ ID NO.1 and a BamHI site GGATCC; tobacco etch virus cysteine protease cleavage site GAGAACCTGTACTTCCAATCC; ndeI restriction enzyme site CATATG; a super-folded Venus fluorescent protein coding sequence; xhoI cleavage site CTCGAG;6 histidine sites and stop codon TAG.
2. The method for purifying the expression vector of the membrane protein SohB according to claim 1, which is characterized by comprising the following specific steps:
step 1, preparation of an escherichia coli membrane protein SohB expression vector mutant strain: transforming an expression vector of membrane protein SohB, namely expression plasmid pLy077-SohB, into host escherichia coli, coating the host escherichia coli with an antibiotic-containing and 0.1mM IPTG agar plate, and selecting yellow-green positive monoclonal bacteria for amplification culture and induced expression;
step 2, inoculating the selected mutant strain transformant into a culture medium for expansion culture, and using 1mM IPTG to induce and express membrane protein SohB on a large scale.
3. The expression purification method according to claim 2, wherein in step 1, the E.coli is E.coli DH 5. Alpha. Or E.coli BL21 (DE 3).
4. The expression purification method according to claim 2, wherein in step 2, the medium is LB medium or TB medium.
CN202010049420.4A 2020-01-16 2020-01-16 Expression vector of membrane protein SohB and expression and purification method thereof Active CN113122561B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010049420.4A CN113122561B (en) 2020-01-16 2020-01-16 Expression vector of membrane protein SohB and expression and purification method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010049420.4A CN113122561B (en) 2020-01-16 2020-01-16 Expression vector of membrane protein SohB and expression and purification method thereof

Publications (2)

Publication Number Publication Date
CN113122561A CN113122561A (en) 2021-07-16
CN113122561B true CN113122561B (en) 2023-08-22

Family

ID=76772185

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010049420.4A Active CN113122561B (en) 2020-01-16 2020-01-16 Expression vector of membrane protein SohB and expression and purification method thereof

Country Status (1)

Country Link
CN (1) CN113122561B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180251738A1 (en) * 2015-08-21 2018-09-06 Manus Bio, Inc. Increasing productivity of e. coli host cells that functionally express p450 enzymes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180251738A1 (en) * 2015-08-21 2018-09-06 Manus Bio, Inc. Increasing productivity of e. coli host cells that functionally express p450 enzymes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Identification of the Escherichia coli sohB Gene, a Multicopy Suppressor of the HtrA (DegP) Null Phenotype;Baird et al.;《JOURNAL OF BACTERIOLOGY》;19920930;第173卷(第18期);材料方法部分、第5767页左栏第1-2段以及图2-3 *

Also Published As

Publication number Publication date
CN113122561A (en) 2021-07-16

Similar Documents

Publication Publication Date Title
CN111454978B (en) Surface display engineering bacterium for specifically adsorbing heavy metal lead and construction method and application thereof
CN111304232B (en) Method for purifying protein based on membrane surface fusion expression strategy and application thereof
CN111850007B (en) Cellulosobody docking protein combination mutant 36864 applicable to low calcium ion concentration and application
CN113621638A (en) Method for constructing Escherichia coli producing L-serine
CN110257356B (en) Enzyme capable of being used for synthesizing carnosine and coding gene thereof
CN111848758B (en) Cellulosome docking protein mutant suitable for low calcium ion concentration and application
CN114774452B (en) Construction method and application of engineering escherichia coli for adsorbing mercury ions in solution
CN113151214B (en) Protein PnlipA with lipase activity and gene and application thereof
CN112592877B (en) Recombinant escherichia coli for over-expressing lsrC gene and construction method and application thereof
CN114875004B (en) High-stereoselectivity R-transketolase mutant and encoding gene and application thereof
CN111848757B (en) Cellulosome docking protein combined mutant 36862 suitable for low calcium ion concentration and application
CN111850005B (en) Cellulosome docking protein combined mutant 36863 suitable for low calcium ion concentration and application
CN115216485A (en) Amikacin-resistant recombinant plasmid pET28a (+) -rmtB and application thereof
CN113122561B (en) Expression vector of membrane protein SohB and expression and purification method thereof
CN113383080B (en) Bacterial expression vectors for increasing protein secretion
CN113122558B (en) Expression vector of membrane protein AmpG and expression and purification method thereof
CN114150002A (en) Light-operated gene switch and application thereof
CN113136395A (en) Expression vector of membrane protein YcbM and expression and purification method thereof
CN113136394A (en) Expression vector of membrane protein CcmB and expression purification method thereof
CN113122559A (en) Expression vector of membrane protein SecF and expression and purification method thereof
CN113122562A (en) Expression vector of membrane protein YddG and expression and purification method thereof
CN113122560A (en) Expression vector of membrane protein FieF and expression and purification method thereof
CN113122557A (en) Expression vector of membrane protein AmtB and expression purification method thereof
CN111850006B (en) Cellulosome docking protein combined mutant 36865 suitable for low calcium ion concentration and application
CN114591985B (en) Mutant pectin lyase and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant